Hundreds of tissue regeneration medical devices seized for alleged patent infringement and potential health risks

These devices lacked essential medical certifications, representing a risk to public health and patient safety. This may result in adverse effects, allergic reactions and rejection of the treated tissues, among other possible health effects.  These devices lacked essential medical certifications, representing a risk to public health and patient safety. This may result in adverse effects, allergic reactions and rejection of the treated tissues, among other possible health effects.  The main...

These devices lacked essential medical certifications, representing a risk to public health and patient safety. This may result in adverse effects, allergic reactions and rejection of the treated tissues, among other possible health effects. 

The main charges include Criminal Association (Art. 416) for being part of a stable organization to commit continuous crimes related to the counterfeiting and commercialization of medical devices; and Counterfeiting and Alteration of Industrial Patents (Arts. 473 and 517-ter), for imitating the patented Rigenera® technology for the regeneration of tissue such as hair or cartilage and being produced and commercialized without medical certifications.

With the decision to seize all allegedly counterfeit devices, the Court reinforces the position of Rigenera HBW and its official distributor, Regenera Activa, in defense of public health and technological innovation.

About Rigenera® technology 

Rigenera® was created to democratize regenerative medicine and improve the quality of life of patients. This technology, patented and produced by Rigenera HBW and distributed only by Regenera Activa, provides patients with a unique and innovative minimally invasive solution based on autologous micro-grafts of biological compounds with unmanipulated progenitor cells. This makes it possible to regenerate tissues of the human body and to treat pathologies such as osteoarthritis, chronic wound healing or androgenic alopecia more quickly and effectively. With over 10 years of experience, the technology is used by 10,000 doctors worldwide, more than 450,000 treatments have been performed and it is supported by more than 80 scientific studies. 

 

 

View original content:https://www.prnewswire.co.uk/news-releases/hundreds-of-tissue-regeneration-medical-devices-seized-for-alleged-patent-infringement-and-potential-health-risks-302385005.html